Impactful market access and evidence strategies for rare disease therapeutics and innovative technologies.
Alkemi delivers evidence and value communication strategies for innovative medicines and technologies.
Our health economics, outcomes research and market access expertise spans US and global markets. Whether the decision-maker is a payer, regulator, reimbursement agency, hospital c-suite or policymaker, Alkemi can develop an effective evidence communication strategy.
Alkemi is aligned to our client goals – increased healthcare access for patients, improved health outcomes and quantified value for all healthcare stakeholders.
Alkemi Strategies & Solutions
Strategies & Evidence
Compelling Value Demonstration for Patient Access
We identify measures of value and define product impact in clinical, humanistic, and economic terms.
We design and execute studies to quantify disease burden, patient outcomes and economic value.
We deliver robust data package for negotiations with regulators, payers and other market access decision makers.
A new client engaged Alkemi in advance of a product launch to develop the value narrative, provide input on data collection and recommend a detailed plan to generate evidence needed for global patient access negotiations.
At project completion the client contracted Alkemi to provide comprehensive HEOR program oversight and plan execution through launch.
Alkemi unlocks value by providing expertise strategy leadership
to enable access to healthcare innovation.